A Salama

Author PubWeight™ 83.38‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med 1994 2.78
2 Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med 1991 2.40
3 Treatment of refractory autoimmune haemolytic anaemia with anti-CD20 (rituximab). Br J Haematol 2001 1.66
4 The effect of the diameter of metal-on-metal bearings on systemic exposure to cobalt and chromium. J Bone Joint Surg Br 2006 1.52
5 Immunoadsorption patients with multiple sclerosis: an open-label pilot study. Eur J Clin Invest 2005 1.50
6 Effect of intravenous immunoglobulin in immune thrombocytopenia. Lancet 1983 1.31
7 Ex vivo antigen preparation for the serological detection of drug-dependent antibodies in immune haemolytic anaemias. Br J Haematol 1984 1.11
8 Diagnosis of gonococcal infection in high risk women using a rapid test. Sex Transm Infect 2006 1.10
9 Metabolite-specific (IgG) and drug-specific antibodies (IgG, IgM) in two cases of trimethoprim-sulfamethoxazole-induced immune thrombocytopenia. Transfusion 1987 1.00
10 Percutaneous management of renal calculi: experience with percutaneous nephrolithotomy in 60 children. J Urol 1999 0.98
11 Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis. Ann Rheum Dis 2008 0.96
12 Rapid detection of heparin-induced platelet antibodies with particle gel immunoassay (ID-HPF4) Lancet 1999 0.95
13 Delayed hemolytic transfusion reactions. Evidence for complement activation involving allogeneic and autologous red cells. Transfusion 1984 0.95
14 Drug-induced immune cytopenias: a unifying pathogenetic concept with special emphasis on the role of drug metabolites. Transfus Med Rev 1990 0.95
15 Efficacy and safety of Privigen, a novel liquid intravenous immunoglobulin formulation, in adolescent and adult patients with chronic immune thrombocytopenic purpura. Hematology 2009 0.95
16 Quinine-induced immune thrombocytopenic purpura followed by hemolytic uremic syndrome. Am J Kidney Dis 1999 0.94
17 Fatal immune haemolysis due to a degradation product of ceftriaxone. Br J Haematol 1999 0.93
18 Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies (anti-Rh0(D). Blut 1984 0.93
19 Immune hemolysis-serological and clinical aspects. Clin Exp Med 2003 0.93
20 Dipeptidyl peptidase IV (DP IV, CD26) in patients with inflammatory bowel disease. Scand J Gastroenterol 2001 0.92
21 The role of metabolite-specific antibodies in nomifensine-dependent immune hemolytic anemia. N Engl J Med 1985 0.91
22 Mycophenolate-mofetil in the treatment of refractory multiple sclerosis. J Neurol 2001 0.91
23 Desipramine reversal of chloroquine resistance in wild isolates of Plasmodium falciparum. Lancet 1990 0.90
24 Management of alloimmune thrombocytopenia. Vox Sang 2007 0.89
25 Beneficial response to rituximab in a patient with haemolysis and refractory Felty syndrome. Ann Rheum Dis 2008 0.88
26 Complete subtyping of the HLA-A locus by sequence-specific amplification followed by direct sequencing or single-strand conformation polymorphism analysis. Tissue Antigens 1995 0.87
27 Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood. Vox Sang 1998 0.87
28 Vesicouterine fistula--variable clinical presentation. Scand J Urol Nephrol 1996 0.86
29 Donor-derived alloantibodies and passenger lymphocyte syndrome in two of four patients who received different organs from the same donor. Transfusion 2001 0.86
30 Treatment of childhood idiopathic thrombocytopenic purpura with Rhesus antibodies (anti-D). Eur J Pediatr 1986 0.86
31 Lack of efficacy of high-dose intravenous immunoglobulin in autoimmune haemolytic anaemia: a clue to its mechanism. Scand J Haematol 1985 0.85
32 Donath-Landsteiner autoimmune hemolytic anemia in children. A study of 22 cases. Vox Sang 1990 0.85
33 Immune tolerance induction in patients with IgA anaphylactoid reactions following long-term intravenous IgG treatment. Clin Exp Immunol 2008 0.85
34 Discrimination of HLA-B27 alleles by group-specific amplification followed by solid-phase sequencing. Hum Immunol 1996 0.84
35 Management of the oral and maxillofacial surgery patient with thrombocytopenia. J Oral Maxillofac Surg 2001 0.84
36 Compatibility and stability of tramadol and dexamethasone in solution and its use in terminally ill patients. J Clin Pharm Ther 2007 0.83
37 Immunomagnetic selection of CD34+ cells: factors influencing component purity and yield. Transfusion 2000 0.83
38 Paradoxical findings in direct antiglobulin test and classification of agglutinating autoantibodies using eluates and monospecific anti-human globulin sera. Vox Sang 2014 0.83
39 Role of glycine in the N-methyl-D-aspartate-mediated neuronal cytotoxicity. J Neurochem 1990 0.83
40 Autoimmune hemolytic anemia associated with an IgA autoanti-Gerbich. Vox Sang 1990 0.81
41 Detection of a new weak A blood-group allele (Aw11). Vox Sang 2006 0.81
42 Interleukin-6 is a major effector molecule of short-term G-CSF treatment inducing bone metabolism and an acute-phase response. Exp Hematol 2001 0.81
43 Deposition of the terminal C5b-9 complement complex on erythrocytes by human red cell autoantibodies. Br J Haematol 1983 0.81
44 6th International Immunoglobulin Symposium: poster presentations. Clin Exp Immunol 2009 0.81
45 Sequence analysis of the 2nd intron revealed common sequence motifs providing the means for a unique sequencing based typing protocol of the HLA-A locus. Tissue Antigens 1996 0.80
46 Increased RBC autoantibody production in pregnancy. Transfusion 2001 0.80
47 Red cell function of carp (Cyprinus carpio) in acute hypoxia. Exp Biol 1987 0.80
48 Identification and characterization of a novel HLA-DRB1 allele, DRB1*0830*. Tissue Antigens 2005 0.80
49 A novel antigen-specific capture assay for the detection of platelet antibodies and HPA-1a phenotyping. Vox Sang 2006 0.80
50 Amlodipine-induced immune thrombocytopenia. Vox Sang 2004 0.80
51 Autoimmune haemolytic anaemia in childhood associated with non-complement binding IgM autoantibodies. Br J Haematol 1987 0.80
52 Effect of IgG anti-Rho(D) in adult patients with chronic autoimmune thrombocytopenia. Am J Hematol 1986 0.80
53 ELISA methods detect HLA antibodies with variable sensitivity. Int J Immunogenet 2006 0.79
54 Binding of fluid phase C3b to nonsensitized bystander human red cells. A model for in vivo effects of complement activation on blood cells. Transfusion 1985 0.79
55 Acute haemolytic transfusion reactions due to weak antibodies that in vitro did not seem to be clinically significant. Vox Sang 2002 0.79
56 Simultaneous genotyping of human platelet antigens (HPA) 1 through 6 using new sequence-specific primers for HPA-5. Transfusion 2000 0.79
57 Dipeptidyl peptidase IV (DPP IV, CD26) in patients with mental eating disorders. Adv Exp Med Biol 2000 0.79
58 [Preoperative identification of patients with impaired (primary) haemostasis. A practical concept]. Hamostaseologie 2007 0.78
59 B*4440: a novel HLA-B allele identified by sequence-specific oligonucleotide hybridization and sequence-specific amplification. Tissue Antigens 2005 0.78
60 Demonstration of drug-dependent antibodies in two patients with neutrophenia and successful treatment with granulocyte-colony-stimulating factor. Transfusion 1999 0.78
61 Two types of nomifensine-induced immune haemolytic anaemias: drug-dependent sensitization and/or autoimmunization. Br J Haematol 1986 0.78
62 The clinical significance of HLA antigens on red cells. Survival studies in HLA-sensitized individuals. Transfusion 1985 0.78
63 Optimum storage conditions for cord blood-derived hematopoietic progenitor cells prior to isolation. Bone Marrow Transplant 2007 0.78
64 Evidence suggesting the occurrence of C3-independent intravascular immune hemolysis. Reactive hemolysis in vivo. Transfusion 1987 0.78
65 Impact of the Gulf war on congenital heart diseases in Kuwait. Int J Cardiol 2004 0.78
66 Quantitative evaluation of elution methods for red cell antibodies. Vox Sang 1984 0.78
67 Massive haemolysis after intramuscular diclofenac in a patient who apparently tolerated oral medication. Vox Sang 2004 0.78
68 Rapid typing of the human neutrophil antigen 1a by the particle gel agglutination assay. Tissue Antigens 2009 0.77
69 Fatal immune haemolysis due to antibodies to individual metabolites of 5-fluorouracil. Transfus Med 2010 0.77
70 Heparin-induced thrombocytopenia: detection of antiheparin/PF4 antibodies by means of heparin/PF4-coated beads and flow cytometry. Transfus Med 2002 0.77
71 Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac) in chronic immune thrombocytopenic purpura. Hematology 2007 0.77
72 Pulsed high-dose dexamethasone in chronic autoimmune haemolytic anaemia of warm type. Br J Haematol 1997 0.77
73 Description of a novel HLA-B allele, B*5613, identified during HLA-typing using sequence-specific oligonucleotide hybridization and sequence-specific amplification. Tissue Antigens 2004 0.77
74 Regulation of ion transport across lamprey (Lampetra fluviatilis) erythrocyte membrane by oxygen tension. J Exp Biol 1998 0.77
75 Assessment of calcium dobesilate in diabetic retinopathy. A double-blind clinical investigation. Ophthalmologica 1977 0.77
76 Comparison of two leukapheresis programs for computerized collection of blood progenitor cells on a new cell separator. Transfusion 2003 0.77
77 Antibodies against protein Z and fetal loss: current perspectives. Clin Exp Med 2005 0.76
78 Detection of germ-cell tumor cells in peripheral blood progenitor cell harvests: impact on clinical outcome. Clin Cancer Res 2000 0.76
79 Tumor necrosis factor alpha enhances the adenoviral transduction of CD34+ hematopoietic progenitor cells. Stem Cells 2004 0.76
80 Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature. Intensive Care Med 2000 0.76
81 Acute treatment with clozapine blocks D1 dopamine receptor binding in discrete brain areas of the male rat. Neurosci Lett 1989 0.76
82 Identification of the novel HLA-A*240215 allele by haplotype-specific sequencing. Tissue Antigens 2008 0.76
83 Protective effects of clioquinol on human neuronal-like cells: a new formulation of clioquinol-loaded PLGA microspheres for Alzheimer's disease. J Drug Target 2010 0.76
84 CD47 is expressed at normal levels in patients with autoimmune haemolytic anaemia and/or immune thrombocytopenia. Transfus Med 2006 0.76
85 On the mechanisms of sensitization and attachment of antibodies to RBC in drug-induced immune hemolytic anemia. Blood 1987 0.76
86 A two-stage immunoradiometric assay with 125I-staphylococcal protein A for the detection of antibodies and complement on human blood cells. Vox Sang 1985 0.76
87 Identification of a novel HLA-B allele, HLA-B*5529, by haplotype-specific sequencing. Tissue Antigens 2008 0.76
88 IgG therapy in autoimmune haemolytic anaemia of warm type. Blut 1984 0.76
89 Detection of tumor cells in peripheral blood samples from patients with germ cell tumors using immunocytochemical and reverse transcriptase-polymerase chain reaction techniques. Bone Marrow Transplant 1998 0.76
90 Characterization of autoantibodies from patients with Goodpasture's disease using a resonant mirror biosensor. Clin Exp Immunol 2002 0.75
91 A novel HLA-B*270509 variant escaping detection by PCR-SSO-based histotyping. Tissue Antigens 2005 0.75
92 Replacement of intravenous administration of anti-D by subcutaneous administration in patients with autoimmune thrombocytopenia. Pediatr Blood Cancer 2006 0.75
93 A novel HLA-A*680104 variant. Tissue Antigens 2006 0.75
94 Identification of a novel HLA-DQB1 allele, HLA-DQB1*0632. Tissue Antigens 2007 0.75
95 Haplotype-specific sequencing reveals a novel HLA-B*37 allele, B*3714. Tissue Antigens 2008 0.75
96 HLA-B7 on human red blood cells. Improved detection by a radioactive anti-IgG test. Tissue Antigens 1982 0.75
97 Vaccination-associated immune hemolytic anemia in two children. Transfusion 2000 0.75
98 Identification of a novel HLA-C*02 allele, HLA-C*02:02:09. Tissue Antigens 2011 0.75
99 Application of the particle gel agglutination assay in the typing of single human leucocyte antigens. Tissue Antigens 2007 0.75
100 Blood constituents in relation to the reproductive state in she-camel (Camelus dromedarius). Beitr Trop Landwirtsch Veterinarmed 1986 0.75
101 New high-performance liquid chromatographic method for fluphenazine and metabolites in human plasma. J Chromatogr 1987 0.75
102 Report of a patient with heparin-induced thrombocytopenia type II associated with IgA antibodies only. Clin Appl Thromb Hemost 2006 0.75
103 Elimination of the prozone effect in the antiglobulin reaction by a simple modification. Vox Sang 1982 0.75
104 A new HLA-B*52 allele, B*52:23, detected in a patient before bone marrow transplantation. Tissue Antigens 2011 0.75
105 A new red blood cell cold autoantibody (anti-Me) Vox Sang 1985 0.75
106 Cianidanol and its metabolites bind tightly to red cells and are responsible for the production of auto- and/or drug-dependent antibodies against these cells. Br J Haematol 1987 0.75
107 Experimental studies of various heating procedures for clinical application of localized hyperthermia. Prog Clin Biol Res 1982 0.75
108 A novel HLA-A30 allele (A*3004) identified by single-strand conformation polymorphism analysis and confirmed by solid-phase sequencing. Tissue Antigens 1995 0.75
109 Rh blood group-specific antibodies in immune hemolytic anemia induced by nomifensine. Blood 1986 0.75
110 [Cold agglutinin disease]. Klin Wochenschr 1988 0.75
111 In vitro fixation of C3d and C5b-9 on platelets by human platelet reactive antibodies. Blut 1989 0.75
112 Nomifensine-induced immune hemolytic anemia and posttransfusion purpura in the same patient. Transfusion 1987 0.75
113 [Autoimmune hemolytic anemia with temporary weakening of Gerbich antigens]. Beitr Infusionsther 1990 0.75
114 [Acute autoimmune hemolytic anemia in childhood caused by Donath-Landsteiner antibodies]. Beitr Infusionsther 1988 0.75
115 [Hemolytic anemia and renal failure caused by nomifensine]. Dtsch Med Wochenschr 1986 0.75
116 A new HLA-C*07 variant allele, C*07:108, identified by sequence-based typing. Tissue Antigens 2011 0.75
117 Human platelet antigen genotyping by using sequence-specific primers and the particle gel agglutination assay. Vox Sang 2005 0.75
118 Alterations in expression and in serum activity of dipeptidyl peptidase IV (DPP IV, CD26) in patients with hyporectic eating disorders. Scand J Immunol 1999 0.75
119 Haemolytic 'efficiency' of C5b-9 complexes in drug-induced immune haemolysis: role of cellular C5b-9 distribution. Br J Haematol 1987 0.75
120 An extended lymphocytotoxicity test for patients treated with lymphocytotoxic antibodies. Vox Sang 2000 0.75
121 Beta-adrenergic stimulation of volume-sensitive chloride transport in lamprey erythrocytes. Physiol Biochem Zool 2001 0.75
122 SERF: a new antigen in the Cromer blood group system. Transfus Med 2004 0.75
123 A new concept for the effector mechanism of intravenous immunoglobulin in hemocytopenias. Blut 1984 0.75
124 [Autoimmune thrombocytopenia, neutropenia and hemolysis]. Internist (Berl) 2009 0.75
125 Storage of RBCs results in an increased susceptibility for complement-mediated degradation. Transfus Med 2014 0.75
126 Follow-up study on 24 patients with nomifensine-induced immune haemolytic anaemia. Transfus Med 1991 0.75
127 [Gel agglutination test--a new test system for semiquantitative detection of feto-maternal transfusion in Rhesus incompatibility]. Z Geburtshilfe Neonatol 2000 0.75
128 Identification of a new HLA-DRB1* 14 allele, DRB1*14:99, by HLA typing of an Asian individual. Tissue Antigens 2011 0.75
129 Identification of a novel HLA-A33 subtype (A*3303) and correction of the A*3301 sequence. Tissue Antigens 1995 0.75
130 [Rhesus(D)-IgG-antibodies in the treatment of autoimmune thrombocytopenia]. Dtsch Med Wochenschr 1992 0.75
131 Major histocompatibility complex markers in patients with nomifensine-induced immune hemolytic anemia. Vox Sang 1988 0.75
132 Idiopathic osteonecrosis of the humeral capitellum. J Bone Joint Surg Br 2008 0.75
133 A rapid gel agglutination test for the determination of fetomaternal haemorrhage. Transfus Med 2007 0.75
134 Rapid detection of autoantibodies to dsDNA with the particle gel immunoassay (ID-PaGIA). Ann Rheum Dis 2002 0.75
135 [Detection of drug-induced antibodies to erythrocytes in the gel test]. Beitr Infusionsther 1993 0.75
136 The diversity of the HLA class I introns reflects the serological relationship of the coding regions. Beitr Infusionsther Transfusionsmed 1997 0.75
137 A novel HLA-A24 allele (A*2405) identified by single-strand conformation polymorphism analysis and confirmed by solid-phase sequencing and isoelectric focusing. Tissue Antigens 1995 0.75
138 Influence of blood donation on levels of water-soluble vitamins. Transfus Med 2008 0.75
139 A simple and practical agglutination assay for human leucocyte antigen-B27 typing. Vox Sang 2006 0.75
140 Pancytopaenia and hepatosplenomegaly in an AIDS patient responding to high dose steroids. Int J STD AIDS 1993 0.75
141 Autoimmune hemolytic anemia caused by a cold agglutinin with a new specificity (anti-Ju). Transfusion 1990 0.75
142 A novel HLA-DQB1*03:02 variant designated DQB1*03:02:05. Tissue Antigens 2011 0.75
143 [Use of 5-fluorouracil chemotherapy in malignant neoplasms of the large intestine]. Prensa Med Argent 1965 0.75
144 Do we have a less severe form of Kawasaki disease or is it the gammaglobulin effect? Int J Cardiol 1999 0.75
145 A novel HLA-DR13 allele (DRB1*1314) identified by single-strand conformation polymorphism analysis and confirmed by direct sequencing. Hum Immunol 1995 0.75
146 Frequencies of alpha4 A3061G variants and identification of three new variants of the human integrin alpha4-subunit. Mol Immunol 2003 0.75
147 Comparison of Neoral and Sandimmune preparations in renal transplant patients--improved pharmacokinetics with neoral. Transplant Proc 1996 0.75
148 Application of the particle gel agglutination system as a new check gel assay for PCR products. Int J Immunogenet 2007 0.75